Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.

作者: Rita Bortell , Joel Moss , Robert C. McKenna , Mark R. Rigby , Dena Niedzwiecki

DOI: 10.4049/JIMMUNOL.167.4.2049

关键词:

摘要: The presence of NAD-metabolizing enzymes (e.g., ADP-ribosyltransferase (ART)2) on the surface immune cells suggests a potential immunomodulatory activity for ecto-NAD or its metabolites at sites inflammation and cell lysis where extracellular levels NAD may be high. In vitro, inhibits mitogen-stimulated rat T proliferation. To investigate mechanism inhibition, effects proliferation were studied using ART2a+ ART2b+ cells. ADP-ribose, but not nicotinamide, inhibited mitogen-activated independent ART2 allele-specific expression. Inhibition by P2 purinergic receptor agonists was comparable to that induced ADP-ribose; these compounds more potent than P1 agonists. Analysis intact demonstrated ADP-ribose predominant metabolite, consistent with glycohydrolase (NADase) activities. Treatment phosphatidylinositol-specific phospholipase C removed much NADase activity, least one having GPI anchor; ART2− subsets contained releasable treatment. Formation AMP from also occurred, result pyrophosphatase activity. Because adenosine, less inhibitory pyrophosphatases serve regulatory role in modifying effect activation. These data suggest express multiple adenine nucleotide-metabolizing activities together modulate function.

参考文章(59)
H G Thiele, A Kashan, F Koch, The rat T-cell differentiation marker RT6.1 is more polymorphic than its alloantigenic counterpart RT6.2. Immunology. ,vol. 65, pp. 259- 265 ,(1988)
Jin Wang, Eiji Nemoto, Gunther Dennert, Regulation of Cytotoxic T Cell Functions by A GPI-Anchored Ecto-ADP-Ribosyltransferase Advances in Experimental Medicine and Biology. ,vol. 419, pp. 191- 201 ,(1997) , 10.1007/978-1-4419-8632-0_24
Rita Bortell, Mark Rigby, Linda Stevens, Joel Moss, Toshihiro Kanaitsuka, John Mordes, Dale Greiner, Aldo Rossini, Mouse RT6 Locus 1 and RAT RT6.2 are NAD+ Advances in Experimental Medicine and Biology. pp. 169- 173 ,(1997) , 10.1007/978-1-4419-8632-0_20
Stefan Karsten, Jens Schröder, Cristina Da Silva, Dominik Kahlke, Heinz-Günter Thiele, Friedrich Koch-Nolte, Friedrich Haag, Expression and Comparative Analysis of Recombinant Rat and Mouse RT6 T Cell Mono(ADP-Ribosyl)Transferases In E. Coli Advances in Experimental Medicine and Biology. ,vol. 419, pp. 175- 180 ,(1997) , 10.1007/978-1-4419-8632-0_21
Dale L. Greiner, Samir Malkani, Toshihiro Kanaitsuka, Rita Bortell, John Doukas, Mark Rigby, Barbara Whalen, Linda A. Stevens, Joel Moss, John P. Mordes, Aldo A. Rossini, The T Cell Marker RT6 in a Rat Model of Autoimmune Diabetes Advances in Experimental Medicine and Biology. ,vol. 419, pp. 209- 216 ,(1997) , 10.1007/978-1-4419-8632-0_26
John P. Mordes, Toshihiro Kanaitsuka, Rita Bortell, Dale L. Greiner, Aldo A. Rossini, Linda A. Stevens, Joel Moss, Mark R. Rigby, Mouse RT6 locus 1 and rat RT6.2 are NAD+. Arginine ADP-ribosyltransferases with auto-ADP-ribosylation activity Advances in Experimental Medicine and Biology. ,vol. 419, pp. 169- 173 ,(1997)
Anders A. F. Sima, Eleazar Shafrir, Animal Models in Diabetes: A Primer ,(2000)
Fernando A.P. Ribeiro-Neto, Rafael Mattera, John D. Hildebrandt, Juan Codina, James B. Field, Lutz Birnbaumer, Ronald D. Sekura, [45] ADP-ribosylation of membrane components by pertussis and cholera toxin Methods in Enzymology. ,vol. 109, pp. 566- 572 ,(1985) , 10.1016/0076-6879(85)09115-7